相关实验视频
Updated: Jun 17, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.4K
在患有帕金森病的老年患者中,深度大脑刺激的安全性和效率
Weidong Wu1,2, Shun Gong1, Shimiao Wang1
1Department of Neurosurgery, General Hospital of Northern Theater Command, Shenyang, China.
CNS neuroscience & therapeutics
|August 7, 2024
概括
机器人辅助深度大脑刺激 (DBS) 对老年帕金森病患者来说是安全有效的,改善了运动功能和日常生活活动. 长期的好处表明,在这个人群中,死亡风险降低.
科学领域:
- 神经外科 神经外科
- 神经学 神经学
- 老年病的医生 老年病的医生
背景情况:
- 由于安全性和有效性问题,深度大脑刺激 (DBS) 在老年患者 (≥75岁) 中未得到充分利用.
- 本研究解决了在这个特定的人口群体中评估DBS的需要.
研究的目的:
- 评估机器人辅助DBS在被诊断患有帕金森病的老年患者中的安全性和有效性.
- 分析运动和非运动结果,日常生活活动和并发症.
主要方法:
- 对40名老年帕金森病患者进行机器人辅助DBS (2016-2021) 的回顾性分析.
- 最低2年的随访,其中一个子组被跟踪了5-7年.
- 评估手术参数,运动/非运动分数,ADL和并发症.
主要成果:
- 机器人辅助的DBS程序准确,并发症率低.
- 2年后,运动症状 (UPDRS III) 和ADL (巴特尔指数) 显著改善.
- 长期随访显示,运动症状恶化,但刺激的益处持续;LEDD增加,平均生存时间为38.3个月.
结论:
- 机器人辅助DBS对于老年帕金森病患者来说是一种安全而准确的程序.
- 运动功能和ADL的显著改善表明神经调节的长期益处.
- 该程序可能会降低这一患者群的死亡风险.
更多相关视频
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.2K
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
8.8K
相关概念视频
Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508